Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03HQK
|
|||
Former ID |
DNC005639
|
|||
Drug Name |
2-(5-Phenyl-oxazol-2-ylamino)-benzonitrile
|
|||
Synonyms |
2-[(5-phenyl-1,3-oxazol-2-yl)amino]benzonitrile; 2-Anilino-5-aryloxazole 8; AC1NS7QZ; CHEMBL193912; BDBM5847; N-(2-Cyanophenyl)-5-phenyl-1,3-oxazol-2-amine Hydrochloride
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H11N3O
|
|||
Canonical SMILES |
C1=CC=C(C=C1)C2=CN=C(O2)NC3=CC=CC=C3C#N
|
|||
InChI |
1S/C16H11N3O/c17-10-13-8-4-5-9-14(13)19-16-18-11-15(20-16)12-6-2-1-3-7-12/h1-9,11H,(H,18,19)
|
|||
InChIKey |
FPMCYJLZCOBPEC-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors. J Med Chem. 2005 Mar 10;48(5):1610-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.